Six figures, six totals, all of them consistent
Each drug gets a month-to-month rate, a quarterly rate with the amount billed every three months, and an annual rate with the amount billed yearly. Multiplying each per-month rate by its term gives the stated total exactly, on all six.
Publishing the billed amount rather than only the implied monthly figure is what lets a reader see the size of the charge that will actually land. Several sellers here publish one and not the other.
The plan table also itemises what the figure includes, down to the injection supplies and the patient portal.
A price you can read and a purchase you cannot make
The semaglutide product page prints the annual rate as an as-low-as figure and then states that the product is out of stock and not available in that quantity.
A published price on an unavailable product is a real thing to record: it is quotable, it is the seller's own, and it is not currently purchasable. Our row carries the plan-table figures, because those are the rates the seller offers across its three terms, and this paragraph carries the stock position.
The two surfaces also lead with different numbers. The product page headline is the annual rate; the plan table leads with the month-to-month rate, which is substantially higher. Which figure a reader meets first depends on which page they land on.
A named company and a stated formulation
The privacy policy names the operating limited liability company with a street address, and the product page states that the medication is compounded rather than leaving the formulation to be inferred.
The plan table says nothing about a membership either way, so that position is recorded as unstated. Sixty-four of the one hundred and fifty-eight sellers here leave it unstated.
No compounding pharmacy is named, no individual clinician is named, and no service area is published.
Tonik Wellness's published pricing
| Medication | Price | Verified |
|---|---|---|
| Semaglutide (compounded) | $225/mothe month-to-month rate; the same table gives $165 a month billed $495 every three months and $149 a month billed $1,788 yearly, and both totals reconcile exactly | September 2026source |
| Tirzepatide (compounded) | $349/mothe month-to-month rate; $249 a month billed $747 quarterly and $229 a month billed $2,748 yearly, both of which also reconcile exactly | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 158 providers reviewed here are paid partners today; the other 154 are not. See how this works.
See Tonik Wellness's current price →Good fit if
- Buyers who want the billed total for each plan term rather than only the per-month figure.
- Readers who want the formulation stated on the product page.
- People who want to know what the price includes down to the supplies.
Look elsewhere if
- Anyone who needs semaglutide now; the product page says it is out of stock.
- Buyers comparing headline figures, which differ sharply between the product page and the plan table.
- Readers who want the compounding pharmacy named.
- People who need a published service area.
How this review was verified
- Read the weight-loss plan table, the semaglutide product page and the privacy policy on 6 September 2026, with a nonsense-path control on the host in the same run.
- Multiplied every stated per-month rate by its term and compared it against the seller's own billed total; all six reconcile.
- Recorded the out-of-stock notice from the page that carries it, beside the price on the same page.
- Took the plan figures from the table that carries all six rather than from either page headline.
- Screened the operating entity and the brand name against FDA's live warning-letter datatable, carrying a known letter as a positive control and a nonsense string as a negative control in the same pass; the positive control returned its letter and the negative returned nothing. Neither the entity nor the brand returned one. Untitled letters are published separately and were not searched, so the supportable claim is that no warning letter was found.